The European pharmaceutical industry has long been recognized for its commitment to innovation, quality, and patient safety. As pharmaceutical products become more diverse and healthcare delivery evolves, packaging has emerged as a critical factor influencing product protection, regulatory compliance, and user experience.
The Europe pharmaceutical packaging market is projected to increase from USD 36.13 billion in 2026 to USD 62.34 billion by 2035, growing at a CAGR of 6.25%. While overall market expansion is supported by rising pharmaceutical production and healthcare demand, the real transformation is taking place within individual market segments. Material innovations, advanced packaging formats, evolving dosage forms, and changing distribution models are collectively redefining the industry.
Packaging Is Becoming More Than Product Protection
Pharmaceutical packaging now serves multiple purposes beyond safeguarding medicines during storage and transportation. It contributes to regulatory compliance, improves medication adherence, minimizes contamination risks, and supports traceability throughout increasingly complex supply chains.
Manufacturers are also balancing sustainability goals with the need for high-performance materials capable of protecting sensitive drugs from moisture, oxygen, and temperature fluctuations.
This combination of performance and compliance is driving innovation across every segment of the European pharmaceutical packaging market.
Material Innovations Continue to Drive Market Development
Material selection plays a vital role in determining packaging performance, product stability, and environmental impact.
Plastics Continue to Lead the Market
Plastics accounted for approximately 45% of the market in 2025, making them the dominant material category.
Their widespread use can be attributed to several advantages:
- Lightweight construction
- Cost-effective manufacturing
- Excellent chemical resistance
- Flexible design possibilities
- Compatibility with multiple dosage forms
Plastic packaging is commonly used for bottles, blister packs, closures, vials, inhaler components, and pharmaceutical containers because it combines durability with manufacturing efficiency.
Despite increasing environmental scrutiny, plastics remain indispensable for many pharmaceutical applications where product safety is the highest priority.
Multi-Layer Laminates Are Emerging as a High-Growth Segment
While plastics dominate current demand, multi-layer laminates are expected to record the fastest growth during the forecast period.
These advanced materials provide superior protection against:
- Moisture
- Oxygen
- Ultraviolet light
- External contaminants
As biologics, specialty medicines, and temperature-sensitive therapies become more common, pharmaceutical companies are increasingly adopting laminate structures for blister packs, pouches, and sachets.
Ongoing research into recyclable laminate technologies is also improving their sustainability profile.
Packaging Formats Are Becoming More Specialized
Packaging formats continue to evolve alongside modern drug therapies.
Bottles and Jars Remain the Largest Category
Bottles and jars represented around 40% of the packaging market in 2025.
Their continued dominance reflects their versatility across numerous pharmaceutical products, including:
- Tablets
- Capsules
- Syrups
- Nutritional supplements
- Oral liquids
Glass and high-performance plastic bottles remain popular because they provide reliable protection while meeting strict pharmaceutical regulations.
Prefilled Syringes Are Transforming Injectable Drug Delivery
Among all packaging formats, prefilled syringes and cartridges are expected to experience the fastest growth.
Several healthcare trends are supporting this expansion:
- Rising biologics production
- Increased vaccination programs
- Home-based healthcare
- Personalized medicine
- Self-administration therapies
Compared with conventional packaging, prefilled systems improve dosing accuracy, reduce contamination risks, and simplify treatment for patients.
These advantages have made them one of the fastest-growing pharmaceutical packaging categories in Europe.
Dosage Forms Influence Packaging Demand
Every pharmaceutical dosage form requires packaging specifically designed to preserve product integrity while ensuring patient safety.
Oral Solid Medicines Continue to Dominate
Oral solid formulations accounted for approximately 50% of the market in 2025, making them the largest dosage form segment.
Their popularity stems from:
- Ease of administration
- Long shelf life
- Lower manufacturing costs
- High patient acceptance
Packaging for tablets and capsules typically includes blister packs, bottles, cartons, and child-resistant closures that improve both safety and convenience.
Injectable Medicines Are Expanding Rapidly
Injectables represent one of the fastest-growing dosage categories across Europe.
The increasing use of biologics, monoclonal antibodies, specialty drugs, and advanced therapies requires packaging capable of maintaining sterility and product stability throughout distribution.
Demand continues to increase for:
- Sterile vials
- Cartridges
- Prefilled syringes
- Ampoules
These packaging formats play a critical role in protecting highly sensitive pharmaceutical products.
Retail Pharmacies Continue to Lead Distribution
Retail pharmacies remain the primary point of medicine distribution throughout Europe.
Holding approximately 55% market share in 2025, this segment continues to dominate pharmaceutical packaging demand because it serves millions of patients purchasing prescription and over-the-counter medicines.
Packaging supplied to retail pharmacies emphasizes:
- Patient safety
- Easy dispensing
- Regulatory labeling
- Tamper evidence
- Product identification
As prescription volumes continue to rise, demand for standardized pharmaceutical packaging is expected to remain strong.
Online Pharmacies Are Creating New Packaging Requirements
Digital healthcare is reshaping pharmaceutical distribution.
The rapid expansion of online pharmacies has introduced new packaging priorities focused on transportation performance rather than traditional retail presentation.
Packaging designed for e-commerce must provide:
- Enhanced product protection
- Secure sealing
- Temperature stability
- Tamper-evident features
- Efficient shipping performance
Growing consumer preference for home medicine delivery is expected to further accelerate innovation in this segment.
Distribution Networks Continue to Modernize
Distributors and wholesalers remain central to Europe’s pharmaceutical supply chain.
Their logistics operations require packaging capable of withstanding long transportation routes while maintaining medicine quality.
Increasingly, packaging is being integrated with technologies such as:
- RFID tracking
- Serialization systems
- Digital authentication
- Barcode management
- Real-time inventory monitoring
These technologies strengthen supply chain transparency while helping combat counterfeit medicines.
Sustainability Is Influencing Every Market Segment
Environmental considerations now influence nearly every packaging decision.
Across materials, packaging formats, and logistics, manufacturers are investing in solutions that reduce environmental impact while maintaining pharmaceutical-grade performance.
Current sustainability initiatives include:
- Recyclable packaging materials
- Lightweight container designs
- Reduced plastic consumption
- Renewable raw materials
- Improved recycling compatibility
European regulations supporting circular economy objectives continue to encourage long-term investment in environmentally responsible packaging technologies.
Segment Innovation Is Strengthening Competitive Advantage
Leading packaging companies are expanding their portfolios through continuous innovation.
Recent developments include:
- Ready-to-use sterile packaging
- Improved barrier technologies
- Sustainable polymer formulations
- High-performance pharmaceutical glass
- Smart authentication systems
Manufacturers are also collaborating with pharmaceutical companies to develop packaging tailored specifically for emerging drug categories, including biologics and personalized therapies.
These partnerships are helping accelerate commercialization while improving patient outcomes.
Conclusion
The Europe pharmaceutical packaging market is evolving through continuous innovation across every major market segment. From advanced material technologies and specialized packaging formats to changing dosage forms and digital distribution channels, each segment contributes to the industry’s long-term growth.
Although plastics and bottles continue to dominate today’s market, future expansion will increasingly be driven by multi-layer laminates, prefilled syringes, injectable therapies, and digitally enabled packaging solutions. Sustainability initiatives and regulatory requirements will further encourage investment in smarter, safer, and more environmentally responsible packaging.
With the market forecast to reach USD 62.34 billion by 2035, Europe is expected to remain a global leader in pharmaceutical packaging innovation, setting new standards for quality, efficiency, and patient-centered design.
Source : https://www.towardspackaging.com/insights/europe-pharmaceutical-packaging-market-sizing
Submit Press Release on Our Platform for Packaging Industry and Innovations: https://www.towardspackaging.com/press-release-solution
Transform Data into Strategy Access the Free Dashboard: https://www.towardspackaging.com/access-dashboard
To explore detailed insights, customized research, or partnership opportunities, connect with our team today: https://www.towardspackaging.com/contact-us
Stay ahead in the packaging industry follow Towards Packaging on LinkedIn for exclusive market updates, research, and industry insights.